🔗 Share this article

Chancellor Reeves has announced she is preparing "targeted action to tackle household expense issues" in the upcoming financial statement.

Speaking to the BBC, she emphasized that curbing inflation is a joint responsibility of both the administration and the Bank of England.

The United Kingdom's inflation rate is expected to be the most elevated among the G7 advanced economies this year and next.

Possible Energy Cost Interventions

Reports indicate the administration could take action to reduce utility costs, for example by reducing the current 5% level of VAT charged on energy supplies.

Another possibility is to reduce some of the policy costs currently added to household expenses.

Budgetary Limitations and Analyst Predictions

The administration will receive the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for these measures.

The view from the majority of analysts is that the Chancellor will have to introduce higher taxes or expenditure reductions in order to adhere to her declared borrowing rules.

Earlier on Thursday, estimates showed there was a twenty-two billion pound deficit for the Treasury chief to fill, which is at the more modest range of expectations.

"There's a collective job between the Bank of England and the government to bear down further on some of the sources of inflation," the Chancellor told reporters in Washington, at the conferences of the International Monetary Fund and World Bank.

Revenue Pledges and International Concerns

While much of the focus has been on expected tax increases, the Treasury chief said the latest figures from the fiscal watchdog had not altered her vow to manifesto promises not to raise rates on income tax, VAT or social security contributions.

She attributed an "uncertain global environment" with increasing geopolitical and trade concerns for the fiscal tax moves, probably to be directed on those "wealthiest."

Global Trade Tensions

Commenting on concerns about the United Kingdom's trade ties with China she said: "Our security interests always come first."

Last week's declaration by China to increase export controls on critical minerals and other resources that are key for high-technology production led American leader the US President to threaten an further 100% tariff on imports from the Asian country, raising the possibility of an full-scale commercial conflict between the two global powers.

The American finance chief called China's move "commercial pressure" and "a global supply chain power grab."

Questioned on accepting the US offer to join its dispute with China, the Chancellor said she was "very concerned" by Chinese actions and urged the Chinese government "to avoid restrictions and limit trade."

She said the action was "bad for the world economy and generates additional challenges."

"In my view there are fields where we must address Chinese policies, but there are also valuable opportunities to export to China's economy, including financial services and other areas of the economy. We've got to get that balance correct."

The chancellor also affirmed she was cooperating with other major economies "on our own essential resources approach, so that we are less reliant."

NHS Medicine Costs and Funding

The Chancellor also admitted that the cost the National Health Service spends on pharmaceuticals could increase as a consequence of ongoing negotiations with the Trump administration and its drugs companies, in return for reduced taxes and funding.

Some of the biggest global drug companies have said in recent statements that they are either halting or abandoning investments in the UK, with some attributing the low prices they are receiving.

Recently, the government science advisor said the cost the NHS spends on drugs would must rise to prevent firms and drug research funding departing from the United Kingdom.

The Chancellor informed the BBC: "We have seen as a result of the payment system, that clinical trials, innovative medicines have not been offered in the United Kingdom in the manner that they are in other EU nations."

"The objective is to ensure that individuals receiving treatment from the NHS are able to receive the finest life-saving treatments in the globe. And so we are examining these issues, and... aiming to obtain additional capital into Britain."